18156012

Source:http://linkedlifedata.com/resource/pubmed/id/18156012

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013227, umls-concept:C0278678, umls-concept:C0599894, umls-concept:C1521840
pubmed:issue	9605
pubmed:dateCreated	2007-12-24
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18156012-18156031
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2985213R
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Indoles, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Sirolimus, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A, http://linkedlifedata.com/resource/pubmed/chemical/bevacizumab, http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2a, http://linkedlifedata.com/resource/pubmed/chemical/sunitinib, http://linkedlifedata.com/resource/pubmed/chemical/temsirolimus
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1474-547X
pubmed:author	pubmed-author:BaschEthanE, pubmed-author:MotzerRobert JRJ
pubmed:issnType	Electronic
pubmed:day	22
pubmed:volume	370
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2071-3
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:18156012-Angiogenesis Inhibitors, pubmed-meshheading:18156012-Antibodies, Monoclonal, pubmed-meshheading:18156012-Antibodies, Monoclonal, Humanized, pubmed-meshheading:18156012-Carcinoma, pubmed-meshheading:18156012-Costs and Cost Analysis, pubmed-meshheading:18156012-Double-Blind Method, pubmed-meshheading:18156012-Humans, pubmed-meshheading:18156012-Indoles, pubmed-meshheading:18156012-Interferon-alpha, pubmed-meshheading:18156012-Kidney Neoplasms, pubmed-meshheading:18156012-Pyrroles, pubmed-meshheading:18156012-Recombinant Proteins, pubmed-meshheading:18156012-Sirolimus, pubmed-meshheading:18156012-Survival Analysis, pubmed-meshheading:18156012-Vascular Endothelial Growth Factor A
pubmed:year	2007
pubmed:articleTitle	Targeted drugs for metastatic renal cell carcinoma.
pubmed:affiliation	Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. motzerr@mskcc.org
pubmed:publicationType	Journal Article, Comment, Randomized Controlled Trial, Research Support, Non-U.S. Gov't